Keywords: shire, david, pendergast, retire, end, basingstoke, uk-based

Shire's David Pendergast to retire at year end

Article | 26 March 2007

Print This

Basingstoke, UK-based drugmaker Shire says that David Pendergast, president of its human genetic therapies business, is to retire at the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in